Key result
This review examines traditional and modified approaches to managing anticoagulation and antiplatelet therapy in contact sports athletes, noting the absence of clear medical guidelines.
Why the study?
Medical conditions requiring anticoagulation or antiplatelet therapy can severely impact young athletes in contact sports, but clear medical guidelines on their management are lacking.
Should anticoagulation or antiplatelet therapy in contact sports be career limiting?
Should anticoagulation or antiplatelet therapy in contact sports be career limiting?
This review discusses the management of athletes on anticoagulation or antiplatelet therapy, highlighting the lack of clear guidelines and exploring whether these therapies should limit participation in contact sports.
Absent guidelines leave anticoagulation management uncertain for contact sports athletes; prospective studies needed before practice recommendations.
Medical conditions requiring treatment with anticoagulation (AC) or antiplatelet therapy have a huge burden on the average patient, but such conditions can have catastrophic effects on the careers of young, rising athletes, in particular those involved in contact sports at a professional level. Contact sports are defined as sports in which body-to-body contact is expected as part of the game such as football, basketball, soccer and hockey. The rates of injuries in these sports are high increasing the likelihood of bleeding event on AC. The main etiologies requiring AC and antiplatelets in athletes are venous thromboembolism and coronary artery disease, respectively. To date, there are no clear medical guidelines on the management of such conditions in athletes. Herein we review the traditional approach to treating such conditions afflicting athletes as well as more recently modified approaches to answer the ultimate question: should anticoagulation or antiplatelet therapy in contact sports be career limiting?
No takes yet. Share an insight, caveat, or question.
Kichloo et al. (2020) conducted a review in Venous thromboembolism and coronary artery disease in athletes. Anticoagulation and antiplatelet therapy was evaluated. This review examines traditional and modified approaches to managing anticoagulation and antiplatelet therapy in contact sports athletes, noting the absence of clear medical guidelines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: